bisoprolol has been researched along with Hypertrophy, Left Ventricular in 13 studies
Bisoprolol: A cardioselective beta-1 adrenergic blocker. It is effective in the management of HYPERTENSION and ANGINA PECTORIS.
Hypertrophy, Left Ventricular: Enlargement of the LEFT VENTRICLE of the heart. This increase in ventricular mass is attributed to sustained abnormal pressure or volume loads and is a contributor to cardiovascular morbidity and mortality.
| Excerpt | Relevance | Reference |
|---|---|---|
| "5 mg hydrochorothiazide + 5 mg amlodipine, 86 patients with resistant hypertension were randomized to the add-on 25 mg spironolactone (MRB group, n = 46) or 5 mg ramipril (RASB group, n = 40) groups for 12 weeks." | 9.19 | Greater efficacy of aldosterone blockade and diuretic reinforcement vs. dual renin-angiotensin blockade for left ventricular mass regression in patients with resistant hypertension. ( Azizi, M; Bobrie, G; Chatellier, G; Frank, M; Ménard, J; Perdrix, L; Plouin, PF, 2014) |
| " Thirty patients with essential hypertension and left ventricular hypertrophy were studied at baseline after withdrawing all previous treatments and after 6 months of treatment with 5-20 mg of bisoprolol, a new beta-selective agent, to assess its possible action on left ventricular mass." | 9.07 | Effects of bisoprolol on left ventricular hypertrophy in essential hypertension. ( Camacho-Vázquez, C; de Teresa, E; González, M; Tabuenca, MJ, 1994) |
| "This study was conducted on the characteristics of PVC in hypertensive patients with left ventricular hypertrophy and aimed to evaluate the effect of bisoprolol on PVC in Vietnamese patients with hypertension and LVH." | 8.31 | The Effect of Bisoprolol on Premature Ventricular Complex in Vietnamese Patients with Hypertension and Left Ventricular Hypertrophy. ( Bao Nguyen, NN; Huynh, MV; Kim Tran, S; Ngo, TH; Ngoc Huynh, HT; Nguyen, TH; Phuong Nguyen, AT; Vo, CT, 2023) |
| "Hypertensive left ventricular hypertrophy (HTN LVH) is associated with almost threefold increased risk of ventricular tachycardia (VT)/ventricular fibrillation (VF)." | 6.72 | Certain beta blockers (e.g., bisoprolol) may be reevaluated in hypertension guidelines for patients with left ventricular hypertrophy to diminish the ventricular arrhythmic risk. ( Koracevic, G; Lovic, D; Sakac, D; Stojanovic, M; Zdravkovic, M, 2021) |
| "5 mg hydrochorothiazide + 5 mg amlodipine, 86 patients with resistant hypertension were randomized to the add-on 25 mg spironolactone (MRB group, n = 46) or 5 mg ramipril (RASB group, n = 40) groups for 12 weeks." | 5.19 | Greater efficacy of aldosterone blockade and diuretic reinforcement vs. dual renin-angiotensin blockade for left ventricular mass regression in patients with resistant hypertension. ( Azizi, M; Bobrie, G; Chatellier, G; Frank, M; Ménard, J; Perdrix, L; Plouin, PF, 2014) |
| " Thirty patients with essential hypertension and left ventricular hypertrophy were studied at baseline after withdrawing all previous treatments and after 6 months of treatment with 5-20 mg of bisoprolol, a new beta-selective agent, to assess its possible action on left ventricular mass." | 5.07 | Effects of bisoprolol on left ventricular hypertrophy in essential hypertension. ( Camacho-Vázquez, C; de Teresa, E; González, M; Tabuenca, MJ, 1994) |
| "This study was conducted on the characteristics of PVC in hypertensive patients with left ventricular hypertrophy and aimed to evaluate the effect of bisoprolol on PVC in Vietnamese patients with hypertension and LVH." | 4.31 | The Effect of Bisoprolol on Premature Ventricular Complex in Vietnamese Patients with Hypertension and Left Ventricular Hypertrophy. ( Bao Nguyen, NN; Huynh, MV; Kim Tran, S; Ngo, TH; Ngoc Huynh, HT; Nguyen, TH; Phuong Nguyen, AT; Vo, CT, 2023) |
| "Bisoprolol (60 mg/kg body weight per day) was given 30 min or 14 days after MI or sham operation." | 3.70 | Long-term effects of beta-adrenergic blocking agent treatment on hemodynamic function and left ventricular remodeling in rats with experimental myocardial infarction: importance of timing of treatment and infarct size. ( Ertl, G; Gaudron, P; Hu, K, 1998) |
| "Hypertensive left ventricular hypertrophy (HTN LVH) is associated with almost threefold increased risk of ventricular tachycardia (VT)/ventricular fibrillation (VF)." | 2.72 | Certain beta blockers (e.g., bisoprolol) may be reevaluated in hypertension guidelines for patients with left ventricular hypertrophy to diminish the ventricular arrhythmic risk. ( Koracevic, G; Lovic, D; Sakac, D; Stojanovic, M; Zdravkovic, M, 2021) |
| "Bisoprolol and enalapril were similarly effective in lowering blood pressure (BP) in the office and during 24-h monitoring and in reducing the left ventricular mass index in hypertensive patients." | 2.67 | Beta-blockers vs. angiotensin-converting enzyme inhibitors in hypertension: effects on left ventricular hypertrophy. ( Dallocchio, M; Gosse, P; Herrero, G; Roudaut, R, 1990) |
| "Left ventricular hypertrophy was diagnosed using the Sokolow-Lyon indices." | 1.48 | Left ventricular hypertrophy diagnosed after a stroke: a case report. ( Kanyal, R; Umeojiako, WI, 2018) |
| "In bisoprolol-treated animals, systolic blood pressure did not change and was even significantly higher than in controls." | 1.29 | Life survival and cardiovascular structures following selective beta-blockade in spontaneously hypertensive rats. ( Benetos, A; Levy, BI; Poitevin, P; Prost, PL; Safar, ME, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (46.15) | 18.2507 |
| 2000's | 1 (7.69) | 29.6817 |
| 2010's | 3 (23.08) | 24.3611 |
| 2020's | 3 (23.08) | 2.80 |
| Authors | Studies |
|---|---|
| Youssef, AM | 1 |
| Elghoneimy, HA | 1 |
| Helmy, MW | 1 |
| Abdelazeem, AM | 1 |
| El-Khodary, NM | 1 |
| Kim Tran, S | 1 |
| Ngo, TH | 1 |
| Phuong Nguyen, AT | 1 |
| Ngoc Huynh, HT | 1 |
| Vo, CT | 1 |
| Bao Nguyen, NN | 1 |
| Nguyen, TH | 1 |
| Huynh, MV | 1 |
| Koracevic, G | 1 |
| Stojanovic, M | 1 |
| Lovic, D | 1 |
| Zdravkovic, M | 1 |
| Sakac, D | 1 |
| Umeojiako, WI | 1 |
| Kanyal, R | 1 |
| Azizi, M | 1 |
| Perdrix, L | 1 |
| Bobrie, G | 1 |
| Frank, M | 1 |
| Chatellier, G | 1 |
| Ménard, J | 1 |
| Plouin, PF | 1 |
| Watanabe, H | 1 |
| Iwanaga, Y | 1 |
| Miyaji, Y | 1 |
| Yamamoto, H | 1 |
| Miyazaki, S | 1 |
| Minami, N | 1 |
| Yoshikawa, T | 1 |
| Kataoka, H | 1 |
| Mori, N | 1 |
| Nagasaka, M | 1 |
| Kurosawa, H | 1 |
| Kanazawa, M | 1 |
| Kohzuki, M | 1 |
| de Teresa, E | 1 |
| González, M | 1 |
| Camacho-Vázquez, C | 1 |
| Tabuenca, MJ | 1 |
| Benetos, A | 1 |
| Poitevin, P | 1 |
| Prost, PL | 1 |
| Safar, ME | 1 |
| Levy, BI | 1 |
| Díez, J | 1 |
| Laviades, C | 1 |
| Mayor, G | 1 |
| Hu, K | 1 |
| Gaudron, P | 1 |
| Ertl, G | 1 |
| Strauer, BE | 1 |
| Schwartzkopff, B | 1 |
| Gosse, P | 1 |
| Roudaut, R | 1 |
| Herrero, G | 1 |
| Dallocchio, M | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Effect of Amlodipine Versus Bisoprolol on Hypertensive Patients With End-stage Renal Disease on Maintenance Hemodialysis.[NCT04085562] | Phase 4 | 46 participants (Actual) | Interventional | 2019-09-01 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for bisoprolol and Hypertrophy, Left Ventricular
| Article | Year |
|---|---|
Certain beta blockers (e.g., bisoprolol) may be reevaluated in hypertension guidelines for patients with left ventricular hypertrophy to diminish the ventricular arrhythmic risk.
Topics: Bisoprolol; Humans; Hypertension; Hypertrophy, Left Ventricular | 2021 |
4 trials available for bisoprolol and Hypertrophy, Left Ventricular
| Article | Year |
|---|---|
Effect of amlodipine versus bisoprolol in hypertensive patients on maintenance hemodialysis: A randomized controlled trial.
Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Bisoprolol; Blood Pressure; Female; Humans; Hypert | 2021 |
Greater efficacy of aldosterone blockade and diuretic reinforcement vs. dual renin-angiotensin blockade for left ventricular mass regression in patients with resistant hypertension.
Topics: Adolescent; Adult; Aged; Aldosterone; Amiloride; Amlodipine; Angiotensin II Type 1 Receptor Blockers | 2014 |
Effects of bisoprolol on left ventricular hypertrophy in essential hypertension.
Topics: Adult; Aged; Bisoprolol; Echocardiography, Doppler; Exercise Test; Female; Gated Blood-Pool Imaging; | 1994 |
Beta-blockers vs. angiotensin-converting enzyme inhibitors in hypertension: effects on left ventricular hypertrophy.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Analysis of Variance; Angiotensin-Converting Enzyme Inhibi | 1990 |
8 other studies available for bisoprolol and Hypertrophy, Left Ventricular
| Article | Year |
|---|---|
The Effect of Bisoprolol on Premature Ventricular Complex in Vietnamese Patients with Hypertension and Left Ventricular Hypertrophy.
Topics: Bisoprolol; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Quality of Life; Sout | 2023 |
Left ventricular hypertrophy diagnosed after a stroke: a case report.
Topics: Aged, 80 and over; Antihypertensive Agents; Bisoprolol; Cardiomyopathy, Hypertrophic; Chest Pain; Co | 2018 |
Renal denervation mitigates cardiac remodeling and renal damage in Dahl rats: a comparison with β-receptor blockade.
Topics: Adrenergic beta-Antagonists; Animals; Bisoprolol; Blood Pressure; Denervation; Hypertrophy, Left Ven | 2016 |
Effects of exercise and beta-blocker on blood pressure and baroreflexes in spontaneously hypertensive rats.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Baroreflex; Bisoprolol; Blood Pressure; Body Weight; | 2003 |
Life survival and cardiovascular structures following selective beta-blockade in spontaneously hypertensive rats.
Topics: Adrenergic beta-Antagonists; Aging; Animals; Arteries; Bisoprolol; Blood Pressure; Body Weight; Card | 1994 |
Effects of antihypertensive therapy on left ventricular hypertrophy of essential hypertension: a role for insulin-like growth factor I?
Topics: Adult; Aged; Antihypertensive Agents; Bisoprolol; Captopril; Echocardiography; Female; Humans; Hyper | 1993 |
Long-term effects of beta-adrenergic blocking agent treatment on hemodynamic function and left ventricular remodeling in rats with experimental myocardial infarction: importance of timing of treatment and infarct size.
Topics: Adrenergic beta-Antagonists; Animals; Bisoprolol; Body Weight; Disease Models, Animal; Dose-Response | 1998 |
Objectives of high blood pressure treatment: left ventricular hypertrophy, diastolic function, and coronary reserve.
Topics: Antihypertensive Agents; Arterioles; Bisoprolol; Blood Pressure; Coronary Circulation; Diastole; Dil | 1998 |